If I had my druthers, I would rather Neuren remain an independent company for the long term.
How about a 'ticket clipper', permanently running P2 trials in the various indications and progressively licensing out further development to the most appropriate bidder, thereby keeping control of the IP for untested applications.
[Something like that anyway.]
Acadia, page-37
-
- There are more pages in this discussion • 846 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
-0.040(0.30%) |
Mkt cap ! $1.679B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.41 | $13.12 | $4.890M | 370.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 997 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.19 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |